Sanofi India Ltd reports Q3 2026 net profit of ₹116.7 crore, up 53.6% year on year, and declares ₹75 interim dividend
- Revenue was ₹491.7 crore, up 3.4% year on year and 12.3% sequentially.
- PBT-to-net-sales margin was 34%, versus 29% in Q3 2025; no exceptional item was recorded.
- Dividend record date: 5 November 2026; limited review report had no qualification.